نتایج جستجو برای: non alcoholicsteatohepatitis nash

تعداد نتایج: 1327570  

2010
Manopriya T. Priya Dhastagir Sultan Sheriff

It was reported that C-reactive protein (CRP) levels increase in parallel with the progression of chronic liver diseases, such as chronic hepatitis and liver cirrhosis. Inflammatory markers, such as high sensitive C-reactive protein (hsCRP), ferritin, transferrin, albumin, alpha-1 acid glycoprotein (AAG), alpha-2 macroglobulin (AMG), alpha-1 anti-trypsin (AAT) and lipoprotein a [Lp(a)] were mea...

2016
Kinya Okamoto Masahiko Koda Toshiaki Okamoto Takumi Onoyama Kenichi Miyoshi Manabu Kishina Jun Kato Shiho Tokunaga Taka-aki Sugihara Yuichi Hara Keisuke Hino Yoshikazu Murawaki

BACKGROUND & AIMS Simple steatosis (SS) and non-alcoholic steatohepatitis (NASH) are subtypes of non-alcoholic fatty liver disease (NAFLD), and the pathogenic differences between SS and NASH remain unclear. MicroRNAs (miRNAs) are endogenous, non-coding, short RNAs that regulate gene expression. The aim of this study was to use animal models and human samples to examine the relationship between ...

2018
Águeda González-Rodríguez M. Pilar Valdecantos Patricia Rada Annalisa Addante Inés Barahona Esther Rey Virginia Pardo Laura Ruiz Laura M. Laiglesia María J. Moreno-Aliaga Carmelo García-Monzón Aránzazu Sánchez Ángela M. Valverde

OBJECTIVES Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in Western countries. Protein tyrosine phosphatase 1B (PTP1B), a negative modulator of insulin and cytokine signaling, is a therapeutic target for type 2 diabetes and obesity. We investigated the impact of PTP1B deficiency during NAFLD, particularly in non-alcoholic steatohepatitis (NASH). METHODS NA...

Journal: :Applied Mathematics and Computation 2020

2004
Geoffrey C. Farrell Jacob George Arthur J. McCullough

This chapter introduces the history, definitional and semantic issues, spectrum and general importance of non-alcoholic fatty liver diseases (NAFLD). Nonalcoholic steatohepatitis (NASH) is a form of metabolic liver disease in which fatty change (steatosis) is associated with lobular inflammation, hepatocyte injury and/or hepatic fibrosis. It comprises a pathogenic link in the chain of NAFLD tha...

2015
Mariana Verdelho Machado Gregory Alexander Michelotti Guanhua Xie Thiago Pereira de Almeida Jerome Boursier Brittany Bohnic Cynthia D. Guy Anna Mae Diehl Silvia C. Sookoian

BACKGROUND AND AIMS Non-alcoholic steatohepatitis (NASH), the potentially progressive form of nonalcoholic fatty liver disease (NAFLD), is the pandemic liver disease of our time. Although there are several animal models of NASH, consensus regarding the optimal model is lacking. We aimed to compare features of NASH in the two most widely-used mouse models: methionine-choline deficient (MCD) diet...

2015
Philip P. Becker Monika Rau Johannes Schmitt Carolin Malsch Christian Hammer Heike Bantel Beat Müllhaupt Andreas Geier Joerg F. Schlaak

OBJECTIVES Liver biopsies are the current gold standard in non-alcoholic steatohepatitis (NASH) diagnosis. Their invasive nature, however, still carries an increased risk for patients' health. The development of non-invasive diagnostic tools to differentiate between bland steatosis (NAFL) and NASH remains crucial. The aim of this study is the evaluation of investigated circulating microRNAs in ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید